4//SEC Filing
Garay Arpa 4
Accession 0001127602-22-013015
CIK 0000310158other
Filed
May 2, 8:00 PM ET
Accepted
May 3, 4:11 PM ET
Size
8.4 KB
Accession
0001127602-22-013015
Insider Transaction Report
Form 4
Garay Arpa
SVP Human Health Global Mktg.
Transactions
- Exercise/Conversion
Restricted Stock Unit
2022-05-01−866→ 866 totalFrom: 2021-05-01Exp: 2023-05-01→ Common Stock (866 underlying) - Tax Payment
Common Stock
2022-05-01$88.69/sh−247$21,906→ 909 total - Exercise/Conversion
Common Stock
2022-05-01$88.69/sh+866$76,806→ 1,156 total
Footnotes (3)
- [F1]Holdings include shares acquired in dividend reinvestment transactions.
- [F2]Each restricted stock unit represents a contingent right to receive one share of Merck & Co., Inc. common stock.
- [F3]These restricted stock units vest and are distributed as shares of Merck & Co., Inc. common stock in three equal installments on 5/1/2021, 5/1/2022 and 5/1/2023.
Documents
Issuer
Merck & Co., Inc.
CIK 0000310158
Entity typeother
Related Parties
1- filerCIK 0001916360
Filing Metadata
- Form type
- 4
- Filed
- May 2, 8:00 PM ET
- Accepted
- May 3, 4:11 PM ET
- Size
- 8.4 KB